Inoue T, Hirabayashi Y, Mitsui H, Furuta Y, Suda Y, Aizawa S, Ikawa Y
Department of Pathology, Yokohama City University Medical School, Japan.
Leukemia. 1994 Apr;8 Suppl 1:S202-5.
The SV40 large T gene under the control of immunoglobulin enhancer induced hyperproliferation of multi-lineage hematopoiesis in transgenic mice. Hence the disease has been considered to be an appropriate experimental model for MDS-like myelodysplasia, sequential pathological changes in the development of the disease are introduced in the report. Huge splenomegaly was the major gross abnormality, which developed with 100% frequency; neither hepato-renal, nor other thymico-lymphatic involvement was common. During the progressive increase in splenic weight, extensive proliferation of multi-lineage hemopoiesis was prominent, although no differences were apparent in the cellular proportions of each hematopoietic element compared with normal spleens, either in flow-cytometric analysis using markers for each subset of hematopoietic elements, or in the histological findings. In the later phases of the disease, the proliferating cell type tended to shift to a variety of single to oligo-lineage hemopoiesis, but the majority of mice still showed the presence of multi-lineage hemopoiesis; histologically, such hemopoiesis was somewhat dysplastic, but had no apparent nature of leukemic infiltration. Several transplantation-assays essentially supported the low neoplastic potential of proliferating cells even in later phase. A long-term observation was made aiming to induce more frequent transition of this abnormal hemopoiesis into a single-lineage neoplasm by transplantation of pre-onset spleen cells, as well as bone-marrow cells from transgenic mice at an early phase of the disease, into lethally irradiated C57BL/6 mice. This trial resulted in a variety of neoplastic growths in the recipients; not only was myelodysplastic hypercellularity seen, but also, single-lineage hemopoietic malignancies, such as B-cell lymphomas/leukemias, histiocytic malignancies, and even myeloid leukemias. The transition from multi-lineage myelodysplasia into single lineage hemopoiesis at some frequency is reminiscent of myelodysplastic syndromes (MDS) in humans. Higher frequency of transition into lymphoid malignancies may be due partly to the immunoglobulin enhancer used as a promoter unit. The results that the SV40 large T antigen was expressed in every proliferating cells, there was no apparent increase in multi-CSFs activity; together with the results of the transplantation assays suggest that the hyperproliferation of the cells is directly induced by the expression of SV40 large T antigen in the hemopoietic cells themselves.
在免疫球蛋白增强子控制下的SV40大T基因在转基因小鼠中诱导多谱系造血细胞过度增殖。因此,该疾病被认为是MDS样骨髓发育异常的合适实验模型,本报告介绍了该疾病发展过程中的一系列病理变化。巨大脾肿大是主要的大体异常,发生率为100%;肝肾及其他胸腺淋巴组织受累并不常见。在脾脏重量逐渐增加的过程中,多谱系造血细胞广泛增殖较为突出,尽管在使用造血细胞各亚群标志物的流式细胞术分析或组织学检查中,与正常脾脏相比,各造血成分的细胞比例没有明显差异。在疾病后期,增殖细胞类型倾向于转变为多种单谱系或寡谱系造血,但大多数小鼠仍表现为多谱系造血;组织学上,这种造血有一定程度的发育异常,但没有明显的白血病浸润特征。几项移植试验基本上支持即使在疾病后期增殖细胞的肿瘤形成潜能也较低。通过将疾病前期转基因小鼠的脾脏细胞以及骨髓细胞移植到经致死剂量照射的C57BL/6小鼠中,进行了长期观察,旨在诱导这种异常造血更频繁地转变为单谱系肿瘤。该试验在受体中导致了多种肿瘤生长;不仅可见骨髓发育异常的细胞增多,还可见单谱系造血恶性肿瘤,如B细胞淋巴瘤/白血病、组织细胞恶性肿瘤,甚至髓系白血病。多谱系骨髓发育异常以一定频率转变为单谱系造血让人联想到人类的骨髓发育异常综合征(MDS)。向淋巴恶性肿瘤转变的频率较高可能部分归因于用作启动子单位的免疫球蛋白增强子。SV40大T抗原在每个增殖细胞中表达、多集落刺激因子活性没有明显增加的结果;以及移植试验的结果表明,细胞的过度增殖是由造血细胞自身中SV40大T抗原的表达直接诱导的。